Insiders · Profile

O'Connor Donal

Director at Theravance Biopharma. Filing since 16 May 2019. CIK 0001625377

Company
Date
Role
Action
Shares
Amount
Of holding
17 May 2019
Director
Sold, plan not stated
2,673
$53.97K
8.8%
16 May 2019
Director
Sold, plan not stated
1,327
$27.87K
4.2%
2 decisions on file.